These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9236953)

  • 41. Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis.
    Ippen CG; Olin JT; Schneider LS
    Am J Geriatr Psychiatry; 1999; 7(4):321-30. PubMed ID: 10521165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The rate of progression of Alzheimer's disease in the later stages: evidence from the Severe Impairment Battery.
    Wild KV; Kaye JA
    J Int Neuropsychol Soc; 1998 Sep; 4(5):512-6. PubMed ID: 9745240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease.
    Eisdorfer C; Cohen D; Paveza GJ; Ashford JW; Luchins DJ; Gorelick PB; Hirschman RS; Freels SA; Levy PS; Semla TP
    Am J Psychiatry; 1992 Feb; 149(2):190-4. PubMed ID: 1734738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.
    Schneider LS; Olin JT; Doody RS; Clark CM; Morris JC; Reisberg B; Schmitt FA; Grundman M; Thomas RG; Ferris SH
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S22-32. PubMed ID: 9236949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there correlation between cognition and functionality in severe dementia? the value of a performance-based ecological assessment for Alzheimer's disease.
    Wajman JR; Oliveira FF; Marin SM; Schultz RR; Bertolucci PH
    Arq Neuropsiquiatr; 2014 Nov; 72(11):845-50. PubMed ID: 25410450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
    Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
    Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.
    Morris JC; Ernesto C; Schafer K; Coats M; Leon S; Sano M; Thal LJ; Woodbury P
    Neurology; 1997 Jun; 48(6):1508-10. PubMed ID: 9191756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of the Greek severe impairment battery (SIB).
    Konsta A; Bonti E; Parlapani E; Athanasiadis L; Kechayas P; Karagiannidou M; Fokas K
    Int Psychogeriatr; 2014 Apr; 26(4):591-6. PubMed ID: 24443975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.
    Tractenberg RE; Weiner MF; Patterson MB; Gamst A; Thal LJ
    J Geriatr Psychiatry Neurol; 2002; 15(2):110-7. PubMed ID: 12083593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of global change in Alzheimer's disease: identifying consensus.
    Olin JT; Schneider LS; Doody RS; Clark CM; Ferris SH; Morris JC; Reisberg B; Schmitt FA
    J Geriatr Psychiatry Neurol; 1996 Oct; 9(4):176-80. PubMed ID: 8970010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deterioration of functional capacities in Alzheimer's disease after a 1-year period.
    Loewenstein DA; Duara R; Rubert MP; Arguelles T; Lapinski KJ; Eisdorfer C
    Int Psychogeriatr; 1995; 7(4):495-503. PubMed ID: 8833273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Mackell JA; Ponton M; Ferreira P; Wilson J; Pawluczyk S; Pfeiffer E; Thomas RG; Jin S; Schafer K; Schittini M; Grundman M; Ferris SH; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S57-64. PubMed ID: 9236954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Course of Cognitive Functioning in Institutionalized Persons With Moderate to Severe Dementia: Evidence From the Severe Impairment Battery Short Version.
    Wolf ET; Weeda WD; Wetzels RB; de Jonghe JFM; Koopmans RCTM
    J Int Neuropsychol Soc; 2019 Feb; 25(2):204-214. PubMed ID: 30457078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.